Atlas Trials

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

Clinical trial NCT04636775 · UNKNOWN

Trial details

NCT number
NCT04636775
Sponsor
Jun Zhang, MD, PhD
Status
UNKNOWN
Study type
OBSERVATIONAL
NSCLC Stage IVNSCLC, Recurrent
Start date
2020-07-29
Primary completion
2024-08-30
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.